723 related articles for article (PubMed ID: 33444702)
1. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
[TBL] [Abstract][Full Text] [Related]
2. A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection.
Humphries F; Shmuel-Galia L; Jiang Z; Wilson R; Landis P; Ng SL; Parsi KM; Maehr R; Cruz J; Morales-Ramos A; Ramanjulu JM; Bertin J; Pesiridis GS; Fitzgerald KA
Sci Immunol; 2021 May; 6(59):. PubMed ID: 34010139
[TBL] [Abstract][Full Text] [Related]
3. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
[TBL] [Abstract][Full Text] [Related]
4. Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells.
Loo SL; Wark PAB; Esneau C; Nichol KS; Hsu AC; Bartlett NW
Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L926-L931. PubMed ID: 32903043
[TBL] [Abstract][Full Text] [Related]
5. Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E).
Parang K; El-Sayed NS; Kazeminy AJ; Tiwari RK
Molecules; 2020 May; 25(10):. PubMed ID: 32429580
[TBL] [Abstract][Full Text] [Related]
6. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.
Liu W; Reyes HM; Yang JF; Li Y; Stewart KM; Basil MC; Lin SM; Katzen J; Morrisey EE; Weiss SR; You J
J Virol; 2021 May; 95(12):. PubMed ID: 33789998
[TBL] [Abstract][Full Text] [Related]
7. A synthetic STING agonist inhibits the replication of human parainfluenza virus 3 and rhinovirus 16 through distinct mechanisms.
Zhu Q; Hu H; Liu H; Shen H; Yan Z; Gao L
Antiviral Res; 2020 Nov; 183():104933. PubMed ID: 32949635
[TBL] [Abstract][Full Text] [Related]
8. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
[TBL] [Abstract][Full Text] [Related]
9. Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses
Stone NE; Jaramillo SA; Jones AN; Vazquez AJ; Martz M; Versluis LM; Raniere MO; Nunnally HE; Zarn KE; Nottingham R; Ng KR; Sahl JW; Wagner DM; Knudsen S; Settles EW; Keim P; French CT
mBio; 2021 Jan; 12(1):. PubMed ID: 33468703
[TBL] [Abstract][Full Text] [Related]
10. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
[TBL] [Abstract][Full Text] [Related]
11. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2
Good SS; Westover J; Jung KH; Zhou XJ; Moussa A; La Colla P; Collu G; Canard B; Sommadossi JP
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558299
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological activation of STING blocks SARS-CoV-2 infection.
Li M; Ferretti M; Ying B; Descamps H; Lee E; Dittmar M; Lee JS; Whig K; Kamalia B; Dohnalová L; Uhr G; Zarkoob H; Chen YC; Ramage H; Ferrer M; Lynch K; Schultz DC; Thaiss CA; Diamond MS; Cherry S
Sci Immunol; 2021 May; 6(59):. PubMed ID: 34010142
[TBL] [Abstract][Full Text] [Related]
13. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
14. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
Gudmundsdottir Á; Scheving R; Lindberg F; Stefansson B
J Med Virol; 2021 Mar; 93(3):1792-1795. PubMed ID: 32975843
[TBL] [Abstract][Full Text] [Related]
16. Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses.
Hu Y; Ma C; Szeto T; Hurst B; Tarbet B; Wang J
ACS Infect Dis; 2021 Mar; 7(3):586-597. PubMed ID: 33645977
[TBL] [Abstract][Full Text] [Related]
17. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures.
Chan RW; Chan MC; Agnihothram S; Chan LL; Kuok DI; Fong JH; Guan Y; Poon LL; Baric RS; Nicholls JM; Peiris JS
J Virol; 2013 Jun; 87(12):6604-14. PubMed ID: 23552422
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery.
Mulay A; Konda B; Garcia G; Yao C; Beil S; Villalba JM; Koziol C; Sen C; Purkayastha A; Kolls JK; Pociask DA; Pessina P; de Aja JS; Garcia-de-Alba C; Kim CF; Gomperts B; Arumugaswami V; Stripp BR
Cell Rep; 2021 May; 35(5):109055. PubMed ID: 33905739
[TBL] [Abstract][Full Text] [Related]
19. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.
Persoons L; Vanderlinden E; Vangeel L; Wang X; Do NDT; Foo SC; Leyssen P; Neyts J; Jochmans D; Schols D; De Jonghe S
Antiviral Res; 2021 Sep; 193():105127. PubMed ID: 34217752
[TBL] [Abstract][Full Text] [Related]
20. HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
Milewska A; Chi Y; Szczepanski A; Barreto-Duran E; Dabrowska A; Botwina P; Obloza M; Liu K; Liu D; Guo X; Ge Y; Li J; Cui L; Ochman M; Urlik M; Rodziewicz-Motowidlo S; Zhu F; Szczubialka K; Nowakowska M; Pyrc K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33219167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]